CN Stock MarketDetailed Quotes
002728 Teyi Pharmaceutical Group
- 9.10
- +0.15+1.68%
Market Closed Dec 27 15:00 CST
4.65BMarket Cap65.94P/E (TTM)
9.27High8.87Low146.74KlotVolume8.94Open8.95Pre Close132.94MTurnover3.92%Turnover Ratio18.35P/E (Static)510.79MShares12.9352wk High2.67P/B3.41BFloat Cap6.7952wk Low9.85Limit Up374.66MShs Float20.62Historical High8.06Limit Down4.47%Amplitude2.21Historical Low0.36Dividend TTM9.06Avg Price66.72KlotAsk3.92%Div YieldTTM100Lot Size71.69KlotBid
Teyi Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -28.07%462.72M | -26.25%330.87M | -30.26%163.08M | -2.65%925.02M | 6.65%643.33M | 19.52%448.65M | 40.63%233.85M | 24.39%950.22M | 3.04%603.23M | -8.36%375.39M |
| Cash received relating to other operating activities | -51.34%8.27M | -60.41%5.55M | 91.58%4.2M | -1.99%21.31M | -11.44%16.99M | -17.39%14.03M | -69.18%2.19M | 79.85%21.74M | 136.10%19.18M | 150.74%16.98M |
| Cash inflows from operating activities | -28.67%470.99M | -27.29%336.42M | -29.13%167.28M | -2.64%946.32M | 6.09%660.31M | 17.92%462.67M | 36.13%236.04M | 25.25%971.96M | 4.87%622.41M | -5.78%392.37M |
| Goods services cash paid | -2.57%258.72M | 14.01%198.89M | -2.51%91.68M | 17.37%350.82M | -0.08%265.53M | 3.00%174.46M | 29.51%94.04M | 25.40%298.89M | 19.63%265.74M | 11.47%169.38M |
| Staff behalf paid | -5.64%78.46M | -6.95%54.3M | -18.14%29.46M | 20.62%108.42M | 22.17%83.15M | 25.36%58.36M | 42.23%35.98M | 4.15%89.88M | 5.62%68.05M | 6.16%46.55M |
| All taxes paid | -42.49%47.86M | -39.69%41.71M | 7.65%36.87M | 51.00%101.92M | 79.21%83.22M | 99.87%69.17M | 73.97%34.25M | -0.65%67.5M | -3.08%46.44M | 3.30%34.61M |
| Cash paid relating to other operating activities | -20.48%124.23M | -17.73%84.18M | 8.45%48.65M | 29.57%186.61M | 35.79%156.21M | 37.33%102.33M | 53.83%44.86M | 13.78%144.03M | 26.03%115.04M | 7.61%74.51M |
| Cash outflows from operating activities | -13.41%509.26M | -6.24%379.09M | -1.18%206.65M | 24.56%747.77M | 18.74%588.11M | 24.38%404.31M | 42.50%209.13M | 15.62%600.3M | 16.33%495.27M | 8.88%325.05M |
| Net cash flows from operating activities | -153.01%-38.27M | -173.11%-42.67M | -246.31%-39.38M | -46.58%198.56M | -43.21%72.21M | -13.30%58.37M | 1.02%26.91M | 44.72%371.66M | -24.22%127.14M | -42.89%67.32M |
| Investing cash flow | ||||||||||
| Cash received from returns on investments | 602.52%1.9M | --1.05M | --21.47K | 6.29%360.81K | -20.44%270.08K | ---- | ---- | -94.62%339.46K | -94.62%339.46K | -95.84%262.39K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -98.10%2.94K | -99.29%1.1K | --500 | 65.48%155.14K | 67.04%155.14K | 144.43%153.99K | ---- | -82.02%93.75K | 2,606.18%92.88K | --63K |
| Cash received relating to other investing activities | --477.01M | --250.01M | --20M | 82.50%73M | ---- | ---- | ---- | -85.71%40M | -85.71%40M | -89.29%30M |
| Cash inflows from investing activities | 112,525.90%478.91M | 162,934.99%251.06M | --20.02M | 81.82%73.52M | -98.95%425.22K | -99.49%153.99K | ---- | -86.20%40.43M | -85.88%40.43M | -89.41%30.33M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 24.61%76.64M | 36.33%62.66M | 23.86%23.82M | -4.67%86.05M | 6.68%61.51M | 12.81%45.96M | -1.92%19.24M | -17.62%90.26M | -33.57%57.65M | -19.63%40.74M |
| Cash paid to acquire investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 116.00%13.5M | 116.00%13.5M | 116.00%13.5M |
| Cash paid relating to other investing activities | 5,223.15%692.01M | --357.01M | --43.01M | 82.50%73M | -67.50%13M | ---- | ---- | 33.33%40M | 33.33%40M | 33.33%40M |
| Cash outflows from investing activities | 931.67%768.65M | 813.13%419.67M | 247.46%66.83M | 10.63%159.05M | -32.97%74.51M | -51.23%45.96M | -69.52%19.24M | -1.41%143.76M | -9.65%111.15M | 8.39%94.24M |
| Net cash flows from investing activities | -291.12%-289.74M | -268.10%-168.61M | -143.37%-46.81M | 17.23%-85.53M | -4.75%-74.08M | 28.34%-45.81M | 69.52%-19.24M | -170.17%-103.33M | -143.31%-70.72M | -132.06%-63.92M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -95.31%13.28M | -4.57%13.28M | -7.21%12.92M | --282.83M | --283.2M | --13.92M | --13.92M | ---- | ---- | ---- |
| Cash from borrowing | 92.94%820M | 63.76%450.35M | 260.00%180M | -17.92%626.63M | -44.36%425M | -58.21%275M | -78.17%50M | 76.37%763.45M | 72.43%763.88M | 73.39%658M |
| Cash received relating to other financing activities | 140.00%480M | 50.00%300M | --100M | --200M | --200M | --200M | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 44.60%1.31B | 56.19%763.63M | 358.26%292.92M | 45.32%1.11B | 18.89%908.2M | -25.70%488.92M | -72.09%63.92M | 23.58%763.45M | 72.43%763.88M | 73.39%658M |
| Borrowing repayment | -29.43%486M | -43.21%306M | 73.04%190M | 86.82%965.88M | 36.10%688.68M | 20.54%538.8M | -64.23%109.8M | -38.17%517M | -31.17%506M | -31.77%447M |
| Dividend interest payment | 23.13%187.78M | 20.29%182.37M | 141.29%1.39M | 0.95%149.02M | -1.38%152.5M | -1.08%151.61M | -76.04%575.08K | 6.67%147.62M | 7.25%154.64M | 7.57%153.26M |
| Cash payments relating to other financing activities | 477.86%577.86M | --413.98M | --180M | -50.00%100M | -50.00%100M | ---- | ---- | --200M | --200M | --200M |
| Cash outflows from financing activities | 32.99%1.25B | 30.70%902.35M | 236.48%371.39M | 40.51%1.21B | 9.36%941.18M | -13.73%690.41M | -64.33%110.38M | -11.28%864.62M | -2.12%860.64M | 0.33%800.26M |
| Net cash flows from financing activities | 286.92%61.65M | 31.15%-138.72M | -68.92%-78.47M | -4.22%-105.44M | 65.91%-32.98M | -41.63%-201.49M | 42.22%-46.46M | 71.64%-101.17M | 77.82%-96.76M | 65.97%-142.26M |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | -664.26%-266.37M | -85.26%-350M | -324.61%-164.66M | -95.46%7.59M | 13.59%-34.85M | -36.06%-188.93M | 66.82%-38.78M | 253.16%167.16M | 61.67%-40.34M | -37.69%-138.86M |
| Add:Begin period cash and cash equivalents | 1.41%546.82M | 1.41%546.82M | 1.41%546.82M | 44.93%539.23M | 44.93%539.23M | 44.93%539.23M | 44.93%539.23M | 14.58%372.07M | 14.58%372.07M | 14.58%372.07M |
| End period cash equivalent | -44.40%280.45M | -43.82%196.81M | -23.64%382.15M | 1.41%546.82M | 52.04%504.38M | 50.21%350.3M | 96.10%500.45M | 44.93%539.23M | 51.13%331.74M | 4.16%233.21M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
